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ABSTRAK 
Pamungkas FA, Sianturi RG, Wina E, Kusumaningrum DA. 2016. Nanopartikel chitosan hormon hCG (Human Chorionic 
Gonadotrophin) dalam meningkatkan induksi ovulasi pada sapi perah. JITV 21(1): 34-40. DOI: 
http://dx.doi.org/10.14334/jitv.v21i1.1343 
Suatu sistem rilis hormon hCG (human chorionic gonadotropin) yang terkontrol membantu mengatasi degradasi hormon 
hCG yang cepat dalam darah dan menghindari penggunaan injeksi hormon berkali-kali untuk tujuan induksi ovulasi serta 
meningkatkan efektifitas reproduksi. Penelitian bertujuan mempersiapkan nanopartikel chitosan hormon hCG (CS-NPh) serta 
mengetahui efektifitas penggunaannya melalui nasal spray. Paramater yang diamati meliputi karakteristik sifat fisikokimia CS-
NPh dan pengamatan ukuran folikel, korpus luteum, waktu ovulasi dan onset berahi setelah pemberian CS-NPh secara nasal 
spray dibandingkan dengan hCG secara intramuskular (kontrol) dengan dosis 1.000 IU pada sapi perah. Hasil penelitian 
menunjukkan bahwa karakteristik sifat fisikokimia CS-NPh masih dalam rentang ukuran nanopartikel dengan distribusi massa 
molekul yang baik dan lebih stabil, sehingga dapat digunakan sebagai komponen pembawa hormon. Hasil penelitian diperoleh 
bahwa waktu ovulasi setelah pemberian hormon hCG secara intramuskular (hari ke 3,13±0,35) dan CS-NPh secara nasal spray 
(hari ke 3,33±0,49) dengan ukuran folikel yang diovulasikan berturut-turut sebesar 1,62±0,22 dan 1,76±0,28 cm tidak 
menunjukkan perbedaan yang nyata (p>0,05), begitu juga untuk ukuran korpus luteum dan onset berahi. Hal ini menunjukkan 
bahwa pemberian CS-NPh secara nasal spray dapat digunakan dalam meningkatkan induksi ovulasi pada sapi perah. 
Kata Kunci: Nanopartikel, hCG, Nasal Spray, Ovulasi 
ABSTRACT 
Pamungkas FA, Sianturi RG, Wina E, Kusumaningrum DA. 2016. Chitosan nanoparticle of hCG (Human Chorionic 
Gonadotrophin) hormone in increasing induction of dairy cattle ovulation. JITV 21(1): 34-40. DOI: 
http://dx.doi.org/10.14334/jitv.v21i1.1343 
A controlled release delivery system of human chorionic gonadotropin (hCG) hormone helps to overcome the rapid 
degradation of hCG hormone in the blood, to avoid the use of multiple injections for ovulation induction and to enhance 
reproductive efficacy. This study aimed to prepare chitosan nanoparticles hCG (CS-NPh) and to determine its efficacy as nasal 
spray of CS-NPh. The observed parameters include physico-chemical characteristics of CS-NPh and the follicle size, corpus 
luteum, the time of ovulation and onset of estrus performed after administration of CS-NPh as a nasal spray compared with 
intramuscular hCG (control) at a dose of 1,000 IU in dairy cattles. The result showed that the formation of the hormone hCG 
nanoparticles is still in the size range of nanoparticles with a well and more stable molecular mass distribution, so it can be used 
as a carrier component of hormones. The result showed that the time of ovulation after hCG by intramuscular (day to 3.13±0.35) 
and CS-NPh as a nasal spray (days to 3.33±0.49) with the follicle size by 1.62±0.22 and 1.76±0.28 cm showed no significant 
differences (p> 0.05), likewise the size of the corpus luteum and onset of oestrus.. This indicates that administration of CS-NPh 
as a nasal spray can be used in enhancing the induction of ovulation in dairy cattles. 
Key Words: Nanoparticles, hCG, Nasal Spray, Ovulation 
INTRODUCTION 
Estrus synchronization in dairy cattle is used for 
facilitating artificial insemination application, saving 
labor and time in detecting estrus. Estrus 
synchronization is one way of controlling estrus, to 
synchronize pre-ovulation condition, minimize 
variation of follicle maturity, luteolysis and increase 
estrus at the same time which around 20.5 days of 
estrus interval and ovulation (Cavalieri et al. 2004). In 
general, pregnancy rate of Artificial Insemination (AI) 
after an estrus synchronization in cattle was not as 
expected or not consistent due to varied of estrus and 
ovulation time determination due to long estrous cycle 
in cattle (Roelofs et al. 2005). 
Induction of ovulation using Human Chorionic 
Gonadotropin (hCG) hormone injection together with 
estrus synchronization program enabled to determine 
accuracy of estrus and ovulation time which eventually 
gets improving animal fertility (Johnson et al. 2010). 
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Beside giving stress to animal, hCG has fast 
degradation of endopeptidase and exopeptidase in 
pituitary. Another approach is using slow release 
delivery system through implantation method. Hormone 
content packed or attached on matrix nanoparticle using 
biodegradable polymer has been used as potential 
hormone carrier by its capability to improve hormone 
stability and protected from rapid degradation during 
hormone transportation and controlling of bioactive 
agent releasing (Bhadra et al. 2002; Vila et al. 2002; 
Kommareddy et al. 2005; Rather et al. 2013).  
The nasal route has received a great deal of attention 
as a convenient and reliable method for the systemic 
administration of drugs. Nasal delivery has been 
explored as an alternative administration route to target 
drugs directly to the brain via the olfactory neurons 
(Ulrika et al. 2005). Nasal mucociliary clearance is one 
of the most important limiting factors for nasal drug 
delivery. It severely limits the time allowed for drug 
absorption to occur and effectively rules out sustained 
nasal drug administration. However, bioadhesive 
polymers can be used to increase the nasal residence 
time, thus allowing longer absorption times, and to 
achieve a more intimate contact with the nasal mucosa, 
which results in a higher concentration gradient and 
subsequent increased absorption (Ugwoke et al. 2005).  
Another important limiting factor in the nasal 
application is the low permeability of the nasal mucosa 
for the drugs. It seems to be necessary to consider an 
absorption enhancement mechanism for co-
administration of drugs with either mucoadhesive 
polymers or penetration enhancers or combination of 
the two (Vasir et al. 2003). Chitosan nanoparticle may 
strongly bind negatively charged materials such as cell 
surface and mucosal fluid. Mucosal fluid contained 
mucin which had different chemical composition, 
however, some consisted of significant proportion from 
sialic acid. In physiological condition, sialic acid 
carried negative charge causing strong electrostatic 
interaction between mucin and chitosan in soluble 
(Dhawan et al. 2004). 
The purposes of this study were to prepare chitosan 
nanoparticle of hCG hormone and to determine its 
effectivity through its use as nasal spray by observing 
the functional response such as follicle growth, 
ovulation time, and emergence of estrous signs.   
MATERIALS AND METHODS 
Preparation and characterization of chitosan 
nanoparticle of hCG hormone (CS-NPh) were 
conducted in the Reproduction Laboratory of the 
Indonesian Research Institute for Animal Production 
(IRIAP) and Nanotechnology Laboratory of Indonesian 
Center for Agricultural Post Harvest Research and 
Development (ICAPOSTRD). At the same time, in 
vitro examination was conducted in of the Animal 
House of IRIAP. 
Formulation of chitosan nanoparticle of hCG 
hormone  
Chemical materials used in formulation of chitosan 
nanoparticle of hCG were Chitosan (degree of 
deacetylation ≥75%) and sodium tripolyphosphate 
(TPP) produced by Sigma-Aldrich Corporation (St. 
Louis, MN), acetic acid (glacial) produced by Merck 
Millipore Corporation (Darmstadt, Jerman), hCG 
hormone (Choluron®) produced by Intervet/Merck 
Animal Health, Holland. 
Chitosan nanoparticle of hCG hormone was 
arranged by ionic interaction process, in accordance 
with modified procedure performed by Wang et al. 
(2008). Two solution were prepared, namely 0.2% b/v 
of chitosan in 1% v/v acetat acid, and TPP (0.1% b/v) 
that diluted in aquadest. TPP (2.0 ml) solution was 
slowly added using syringe into acetic acid chitosan 
solution (5.0 ml) under 1500-rpm speed magnetic 
stirring until nanoparticle formed. Then hCG hormone 
(Choluron®) was added slowly into chitosan 
nanoparticle solution with concentration established 
was 500 IU/ml under 1500 rpm speed magnetic stirring 
for 10 minutes. As 1 N HCL or NaOH solution was 
added to manage suspension pH at 5.5. 
Characteristics of physicochemical properties of 
chitosan nanoparticle of hCG hormone  
Average size of particle and distribution were 
measured by photon correlation spectroscopy (PCS, 
dynamic light scattering, DLS) technique which is a 
multipurpose tool to estimate distribution of fine 
particle size of a material in range 0.6 nm – 7 µm. As 5 
µm nanoconjugate suspension was diluted in 5 ml 
deionized water and be shaken slowly and then put into 
analyzer. After reaching expected intensity, analysis 
was conducted to obtain average particle size and 
polydispersity index (PDI) of the samples. 
Measurement of zeta potential was a way to know the 
stability of every coloid system which determined by 
electrophoretic light scattering (ELS). 
Evaluation of entrapment efficiency of chitosan 
nanoparticle of hCG hormone 
Entrapment efficiency (EE) process was determined 
by separating nanoparticle from suspension that 
consisting hCG non-entraped with ultra-centrifugation 
at 12.000 rpm, 10ºC for 10 minutes. The amount of free 
hCG hormone in supernatant was measured by 
spectrophotometry UV at λ = 260 nm (Katas et al. 
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2013). Entrapment efficiency (EE%) of hCG in CS-NPh 
was calculated according the following formula: 
EE % = hCG amount – free hCG in supernatant x 100 
Total amount of hCG 
Estrus-ovulation synchronization 
Cows used were 2-5 years old Friesian Holstein 
(FH), at least experienced once bear, non pregnant one, 
and had normal estrus cycle. They were ultrasound 
(USG) first, to monitor ovaries and examine their 
follicles and corpus luteum (CL) condition, Cows, then 
injected with Prostaglandin / PGF2α (Lutalyse® 5-ml) 
intramuscularly (IM) and repeated at day 11. Then, they 
were divided into 2 groups as following: 
Group A : Injected by 1.000 IU hCG hormone 
intramuscularly at day 2 after the last 
Prostaglandin  (PGF2α) injection 
Group B : Chitosan nanoparticle of hCG (CS-
NPh) providing at 1.000 IU by nasal 
spray at day 2 after the last PGF2α 
injection 
Ultrasonography 
USG was conducted to observe the ovarian 
dynamics, by measuring diameter of follicles and CL 
development. Diameter development pattern of follicles 
and CL were monitored using Ultrasonography (brand 
SIUI Veterinary model CST 7700V with 10.4 inchi 
monitor LCD and Linier Rectal Probe 7.5 MHz). USG 
observation was performed everyday started from 
second PGF2α injection until ovulation. Before the 
transrectal USG observation, cow’s feces were emptied 
and dragged first from the rectum. Scanning was 
conducted to right and left ovarium, and diameter of 
entire visible follicles and CL were measured one by 
one. 
Estrus observation 
Observation of estrus was conducted along with 
USG observation. It was focusedon physical changes of 
outside reproduction organs during estrus observation 
such as swelling of vulva, mucus discharged from 
vulva, reddening of vagina mucous, and it was warm if 
touched. 
Data analysis 
Data were analysed by Analysis of Variance 
(ANOVA) and then continued by Dunnet further 
testing. Data were processed by SPSS version 19. 
RESULT AND DISCUSSION 
Chitosan nanoparticle of hCG in this study was 
prepared according to ionic interaction process (ionic 
gelation), where the process of nanoparticle production 
depend on positively charged particles dissolved in 
chitosan molecule while pH had an important role 
during its production process. Characteristic of 
physicochemical properties of chitosan nanoparticle -
hCG hormone was showed in Table 1. 
Table 1. Characteristic of physiochemical properties of 
chitosan nanoparticle of hCG hormone 
Parameters Value 
Particle size (nm) 226.17±26.27  
Polydispersity index  0.301±0.03  
Zeta potential (mV) +21.22±1.51 
entrapment efficiency (%) 54.11±12.94 
Acidity of chitosan nanoparticle-hCG hormone 
formed was at initial pH 3.79±0.04 (not shown in the 
table) and adjusted to pH 5.5. Therefore, the uptake of 
nanoparticle close to neutral pH may prove useful in the 
controlled release of a drug from a pH-sensitive. Low 
pH is a well known sensory irritant in pathological 
conditions such as inflammation in the nasal mucosa. 
Acid exposure cause marked nasal irritation via a 
specific subset of sensory nerves (Dalton et al. 2010). 
Chitosan in acid media might interact with negatively 
charged TPP form inter and intra-moleculs producing 
crossed ionic-chitosan nanoparticle (De Campos et al. 
2001; Xu & Du 2003). Mi et al. (2003) reported that 
TPP diluted in water separated hydroxide ion (OH-) and 
tripolyphosphoric (P3O105-and HP3O104) at pH 9. At 
basic pH, both hydroxide and tripolyphosphoric ions 
competed in ionic reaction with protoned-amino group 
(NH3+) from chitosan solution (pH 3.5) with 
deprotonation or crossed-ion. Availability of protoned-
amino group caused crossed-ionic process easier for 
chitosan with high deacetilation rate (Agnihotri et al. 
2004). Ionic gelation method, nanoparticle was 
produced by spontantenous formation from smaller size 
with positive charge (De Campos et al. 2001; Pan et al. 
2002) at room themperature (Hu et al. 2002).  
Nanoparticle formation by conditioning TPP at acid 
pH (<6) resulting low cutting level of phosphor chain 
and formation of nanoparticle by crossed-ion 
processing. Dudhani & Kosaraju (2010) reported that 
formation of chitosan nanoparticle at pH 4.5, reduced 
the size of particle and increasing zeta potential than the 
one formed at pH 5.5. Zengshuan et al. (2002) reported 
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that efficiency of insulin hormone interaction with 
chitosan nanoparticle at pH 5.3 was lower than at pH 
6.1 but had stronger and more stable charge interaction 
in acidic and enzymatic hydrolysis condition. 
 
 
The distribution of particle size for chitosan 
nanoparticles hCG hormone is given in Tabel 1 and 
Figure 1. The results of this study showed that particle 
size of chitosan nanoparticle- hCG hormone was 
226.17±26.27 nm and polydispersity index (PDI) value 
was 0.301±0.03. Particle size is the most important 
characteristic in nanoparticle system. Particle size in 
this study was in range with nanoparticle size reported 
by Mohanraj & Chen (2006) who said that nanoparticle 
was a dispersion or solid particle around 10-1000 nm  
size. As polydispersity index score was in size range of 
distribution of muleculer mass in certain sample. Result 
showed that PDI score was 0.3, where this score 
showed that calculation result of average molecule 
weight was divided by amount of average molecule 
weight. The closer to zero means that the distribution 
was getting better. 
Average particle size in this study was higher than 
Zhang et al. (2004) who reported that low molecular 
weight chitosan with concentration by 0.1% (w/w) in 
nanoparticle formation resulting distribution of particle 
size by 153-500 nm. Dudhani & Kosaraju (2010) 
reported that formation of catechin chitosan 
nanoparticle at pH 5.5 resulted particle size as 130±5 
nm. Rather et al. (2013) said that particle size of 
chitosan nanoparticle of Luteinizing Hormone 
Releasing Hormone (LHRH) at pH 6.5 was 114±10.3 
nm with PDI score 0.335. In contrast with Zengshuan et 
al. (2002) who reported that formation of chitosan 
nanoparticle of insulin hormone at pH 5.3 resulting 
particle size by 243-271 nm with 0.50-0.57 of PDI 
score. Difference of average particle size and PDI score 
was due to difference in pH and the hormone used. 
Zhang et al. (2004) reported that manipulation of 
charged particle might be performed with varied pH but 
was followed by disintegration of particle due to weak 
interaction of chitosan and TPP (Zhang & Kosaraju, 
2007). 
Surface charge is an important parameter to 
examine stability of suspention and adhesion of 
particular system in biological surface, so that 
evaluation of zeta potential should be an important part 
of nanoparticle. Zeta potential was a surface charge that 
might influence stability of particle in suspention due to 
electrostatic repulsion between particles (Qi et al. 
2004). Zeta potential and entrapment efficiency of 
chitosan nanoparticle- hCG in this study were 
+21.22±1.51 mV and 54.11±12.94 %, respectively. 
Analysis of zeta of chitosan nanoparticle-hCG in 
this study showed positive (+) sign and more than 20 
mv. Positively charged-chitosan nanoparticle was a 
uniq characterization of chitosan/TPP particle. In a 
formation mechanism of particle, positively charged-
amina was neutralized by its interaction with negative 
charge in triphosphaste molecule and recidual amino 
group affecting positive zeta potential (Honary & Zahir 
2013). Higher zeta potency value in certain range 
indicated that chitosan nanoparticle formed was not 
stable. Wang et al. (2008) said that long amino chain 
group might prevent aggregation in nanoparticle. 
hCG hormone was a glycoprotein hormone which 
able to efficiently (90-100%) absorb into polimer at 
around isoelectric pH (pI) of protein due to 
minimalization electrostatic repulsion which  increasing 
of stability conformation and shorter specific surface 
wide of protein molecule (Sanchez et al. 2008). 
Relation of hCG hormone and chitosan might be 
encouraged by hydrophobic interaction between –H 
bond, however its association was relatively unstable 
due to pH change in acid range (Nielsen et al. 2001). 
Wang et al. (2008) reported that chitosan nanoparticle 
of estradiol hormone prepared by ionic glass method 
had zeta potential score and entrapment efficiency by 
+25.4 mV and 67% respectively. While, Rather et al. 
(2013) said that chitosan nanoparticle of Luetinizing 
hormone releasing hormone (LHRH), with same 
method resulted zeta potention score and entrapment 
efficiency by -33.14±6.67 mV and 69% respectively. 
In vivo study was conducted to analyze the 
application method of chitosan nanoparticle-hCG 
hormone (CS-NPh) by nasal spray. Absorption in the 
nasal cavity was faster and there was a direct tract from 
the nasal cavity to central nerve system increasing 
hormone capacity selectively in certain area in brain 
(Wang et al. 2008). Many studies in experimental 
animal showed that hormone concentration in brain was 
higher after hormone application via nasal than via 
intravena injection that showing a tract from nasal to 
brain (Illum 2000; Vyas et al. 2005). Chitosan 
nanoparticle may strongly bind materials such as cell 
surface and mucus. Mucus consisted of mucin which 
has different chemical construction, however some of 
them consisted of different silate acid. At physiologic- 
pH, silate acid carried negative charge causing strong 
Figure 1. Particle size distributions of chitosan nanoparticles of 
hCG hormone 
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interaction between mucin and chitosan in solution 
(Dhawan et al. 2004). Chitosan not only served to 
enhance adhesive between formulation and nasal tissue, 
but also acted in paracellular transportation process 
(Smith et al. 2004). Immunohistological studies have 
shown that chitosan can open the tight junctions 
between cells through an effect upon factin filaments. 
Unlike other absorption promoters, chitosan appears to 
be non-toxic and well tolerated by human subjects. This 
combination of bioadhesion and paracellular transport 
effects has led to a consideration of the use of chitosan 
for the delivery hormone via the nasal cavity (Wang et 
al. 2008). 
Thirteenth of 43 synchronized-cows showed 
ovulation time before hCG providing, so that only 30 
cows were included in the treatment group. This 
possibility due to cows already in luteal phase and 
already had CL after second PGF2α injection, so that 
PGF2α acted to the CL. The lysis of CL decreased the 
progesterone level and causing loss barrier against 
gonadotropine hormone which induced follicle growth 
and maturation, estrus and ovulation. As said by 
Marietta et al. (2001) that PGF2α hormone use for estrus 
syncrionization program was only effective if the 
animals already hada a CL. Then Santos et al. (2001) 
said that PGF2α injection would decrease concentration 
of progesterone in blood so that ratio of concentration 
of estrogen and progesterone increased inducing 
animals showing estrus behaviour and then ovulation 
occured. 
Ovulated follicle size and ovulation time after hCG 
injection intramuscularly and CS-NPh as a nasal spray 
showed in Table 2. Research result showed that hCG 
hormone intramuscularly injection and CS-NPh as a 
nasal spray did not show any significant difference 
(P>0.05) both in size of ovulated follicle and its 
ovulation time. Times of ovulation after hCG providing 
intramuscularly and CS-NPh as a nasal spray were at 
the day- 3.13±0.35 and 3.33±0.49 days, respectively 
with size of ovulated follicle was 1.62±0.22 and 
1.76±0.28 cm, respectively. Time of ovulation related 
to the largest diameter follicle. Safilho et al. (2010) and 
Perry et al. (2005) reported that follicle ovulated in 
cattle, generally had diameter around 1.11-1.44 cm. 
Whereas, Cavalieri et al. (2004) reported that diameter 
of follicle ovulated in FH cattle was around 1.06-1.76 
cm. 
Beside follicle size observation, corpus luteum size 
and estrus onset observation after hCG applying were 
conducted and presented in Table 3. It shows that 
administration of hCG intramuscularly and CS-NPh by 
nasal spray did not show any significant difference 
(P>0/05) both in corpus luteum size or onset of estrus. 
The results of this research also showed that corpus 
luteum size decreased from day-0 to day-4 after the last 
PGF2α injection and hCG by IM (from 2.05±0.46 into 
0.91±0.26 cm) and CS-NPh as a nasal spray (from 
2.16±0.40 into 0.88±0.22 cm). 
Principle of estrus synchronization using PGF2α 
which act as luteolytic agent was regressing CL and 
causing loss of CL function and decline the 
Table 2. Size of folicle ovulated and ovulation after hCG hormone providing 
Group n 
Folicle size (cm) 
Ovulation time  (6th day) 
H0 H1 H2 Before ovulation 
A 15 1.22±0.20 1.40±0.20 1.49±0.21 1.62±0.22 3.13±0.35 
B 15 1.25±0.25 1.42±0.28 1.56±0.28 1.76±0.28 3.33±0.49 
Description: A : 1.000 IU hCG hormone providing intramuscularly 
                 B : 1.000 IU CS-NPh providing by nasal spray  
                   H0 : the last day of PGF2α injection 
                 H1 :-H2: day-1 to day-2 after the last PGF2α injection 
Table 3. Size of corpus lutheum and onset estrus after hCG hormone providing 
Group n 
Size of corpus lutheum (cm) 
Ovulation time (days) 
H0 H1 H2 H3 H4 
A 15 2.05±0.46 1.63±0.38 1.34±0.33 1.11±0.27 0.91±0.26 2.85±0.90 
B 15 2.16±0.40 1.69±0.30 1.36±0.37 1.16±0.38 0.88±0.22 2.62±0.77 
Description: A : 1.000 IU hCG hormone providing intramuscularly 
                 B :  1.000 IU CS-NPh providing by nasal spray  
          H0 : the last day of PGF2α hormone injection 
                  H1-H2 : day-1 to day-2 after the last PGF2α injection 
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progesterone concentration, against gonadotropine and 
there was a growth and maturation of follicle. Beside 
regressing CL, PGF2α also decreased concentration of 
progesterone to less than 1.0 ng/ml within 24 hours 
(Yoshida & Nakao 2005). During estrus cycle, CL was 
an important structure in the term of size and duration. 
Appearance and disappearance of CL were responsible 
to estrus cycle (Hafez & Hafez 2001; Senger 2005). 
Estrus syncrhonization in animal was aimed to 
simultaneous their estrus in the same time. Research 
result showed that the emergence of estrus signs 
(swelling of vulva, mucus discharged from vulva, 
reddening of vagina mucousm, and it was warm if 
touched) after hCG providing intramuscularly and nasal 
spray was at the day- 2.85±0.90 and 2.62±0.77, 
respectively did not showing any significant difference 
(P>0.05). 
CONCLUSION  
Characteristic of chemical properties of particle 
size, polydispersity index, zeta potential and entrapment 
efficiency of chitosan nanoparticle of hCG hormone 
showed that nanoparticle formation of hCG hormone 
using chitosan polimer was still in nanoparticle size 
range and might be used as hormone carrier component. 
Research result showed that time of ovulation after 
hCG providing intramuscularly (day- 3.13±0.35) and 
CS-NPh by nasal spray (day- 3.33±0.49) with size of 
follicles ovulated were 1.62±0.22 and 1.76±0.28 cm, 
respectively. Size of corpus luteum decreased from day-
0 to day-4 after hCG providing intramuscularly (from 
2.05±0.46 into 0.91±0.26 cm) or CS-NPh as a nasal 
spray (from 2.16±0.40 into 0.88±0.22 cm). As well as 
estrus onset and level of progesterone hormone after 
hCG providing intramuscularly did not show any 
significant difference (P>0.05) with CS-NPh as a nasal 
spray. This showed that CS-NPh providing as a nasal 
spray can be used in increasing induction of ovulation 
in dairy cattle. 
ACKNOWLEDGEMENTS 
This study was supported in part by DIPA from 
Indonesian Research Institute for Animal Production 
T.A. 2015 No. 1806.018.003/K-4/APBN 2015. The 
authors wish to thank M. Syaeri, Enok Mardiyah, Aqdi 
Faturahman Arrazy, Nia and Yanti for technical 
assistance and performing assays. 
REFERENCES 
Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. 
Recent advances on chitosan-based micro- and 
nanoparticles in drug delivery. J Controlled Release. 
100:5-28. 
Bhadra D, Bhadra S, Jain P, Jain NK. 2002. Pegnology: a 
review of PEG-ylated systems. Pharmazie. 57:5-29. 
Cavalieri J, Hepworth G, Macmillan KL. 2004. Ovarian 
follicular development in Holstein cows following 
synchronisation of oestrus with oestradiol benzoate and 
an intravaginal progesterone releasing insert for 5–9 
days and duration of the oestrous cycle and 
concentrations of progesterone following ovulation. 
Anim Reprod Sci. 81:177-193. 
Dalton PH, Opiekun RE, Gould M, McDermott R. Wilson T, 
Maute C, Ozdener MH, Zhao K, Emmett E, Lees PSJ, 
Herbert R, Moline J. 2010. Chemosensory loss: 
functional consequences of the world trade center 
disaster. Environ Health Perspect. 118:1251-1256. 
De Campos AM, Sanchez A, Alonso MJ. 2001. Chitosan 
nanoparticles: A new vehicle for the improvement of the 
delivery of drugs to the ocular surface. Application to 
cyclosporin A. Int J Pharm. 224:159-168. 
Dhawan S, Singla AK, Sinha VR. 2004. Evaluation of 
mucoadhesive properties of chitosan microspheres 
prepared by different methods. AAPS Pharm Sci Tech. 
5:122-128. 
Dudhani AR, Kosaraju SL. 2010. Bioadhesive chitosan 
nanoparticles: Preparation and characterization. 
Carbohydrate Polymer. 81:243-251. 
Hafez ESE, Hafez B. 2001. Reproduction in farm animals. 7th 
ed. Philadelphia (USA): Lippincot Williams & Wilkins. 
Honary S, Zahir F. 2013. Effect of zeta potential on the 
properties of nano-drug delivery systems-a review (Part 
1). Trop J Pharm Res. 12:255-264.   
Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. 2002. 
Synthesis and characterization of chitosan–poly (acrylic 
acid) nanoparticles. Biomaterials. 23:3193-3201. 
Illum L. 2000. Transport of drugs from the nasal cavity to the 
central nervous system. Eur J Pharm Sci. 11:1-18. 
Johnson R, William AB, Evelin JC, Victor N, Yoonsung J, 
Melissa M. 2010. Roles of hCG in advancing follicular 
growth to ovulation after concurrent injections of 
PGF2α and GnRH in postpubertal Holstein heifers 
bearing a CL. Vet Medic Int. 2010:1-7. 
Katas H, Raja MAG, Lam KL. 2013. Development of 
chitosan nanoparticles as a stable drug delivery system 
for protein/siRN. Int J Biomater. 2013:1-9. doi: 
10.1155/2013/146320. 
Kommareddy S, Tiwari SB, Amiji MM. 2005. Long-
circulating polymeric nanovectors for tumor-selective 
gene delivery. Technol Cancer Res Treat. 4:615-625. 
Marietta FW, Sayre B, Inskeep EK, Flores JA. 2001. 
Prostaglandin F2α regulation of the bovine corpus 
luteum endothelin system during the early and midluteal 
phase. Biol Reprod. 65:1710-1717. 
 
JITV Vol. 21 No 1 Th. 2016: 34-40 
 40 
Mi FL, Sung HW, Shyu SS, Su CC, Peng CK. 2003. 
Synthesis and characterization of biodegradable 
TPP/genipin co-crosslinked chitosan gel beads. 
Polymer. 44:6521-6530. 
Mohanraj VJ, Chen Y. 2006. Nanoparticles - a review. Tropic 
J Pharm Res. 5:561-573. 
Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, 
Uversky V, Fink AL. 2001. Effect of environmental 
factors on the kinetics of insulin fibril formation: 
Elucidation of the molecular mechanism. Biochemistry. 
40:6036-6046. 
Pan Y, Li Y, Zhao H, Zheng J, Xu H, Wei G. 2002. 
Bioadhesive polysaccharide in protein delivery system: 
Chitosan nanoparticles improve the intestinal absorption 
of insulin in vivo. Int J Pharm. 249:139-147. 
Perry GA, Smith MF, Lucy MC, Green JA, Parks TE, 
Macneil MD, Roberts AJ, Geary TW. 2005. 
Relationship between follicle size at insemination and 
pregnancy success. Proc Natl Acad Sci. 102:5268-5273. 
Qi L, Xu Z, Jiang X, Hu C, Zou X. 2004. Preparation and 
antibacterial activity of chitosan nanoparticles. 
Carbohydrate Res. 339:2693-2700. 
Rather MA, Rupam S, Subodh G, Ferosekhan S, Ramya VL, 
Sanjay BJ. 2013. Chitosan-nanoconjugated hormone 
nanoparticles for sustained surge of gonadotropins and 
enhanced reproductive output in female fish. Plos One. 
8:1-11. 
Roelofs JB, van Eerdenburg FJCM, Soede NM, Kemp. 2005. 
Various behavioral signs of estrous and their 
relationship with time of ovulation in dairy cattle. 
Theriogenology. 63:1366-1377. 
Safilho MF, Crespilho AM, Santos JEP, Perry GA, Baruselli 
PS. 2010. Ovarian follicle diameter at timed 
insemination and estrous response influence likelihood 
of ovulation and pregnancy after estrous 
synchronization with progesterone or progestin-based 
protocols in suckled Bos indicus cows. Anim Reprod. 
Sci. 120:23-30. 
Sanchez S, Roldan M, Perez S, Fabregas E. 2008. Toward a 
fast, easy, and versatile immobilization of biomolecules 
into carbon nanotube/polysulfone-based biosensors for 
the detection of hCG hormone. Anal Chem. 80:6508-
6514. 
Santos JEP, Thatcher WW, Pool L, Ovrton MW. 2001. Effect 
of human chorionic gonadotropin on luteal function and 
reproductive performance of high producing lactating 
Holstein dairy cow. J Anim Sci. 79:2881-2894. 
Senger PL. 2005. Pathways to pregnancy and parturition. 2nd 
ed. Moscow (Russia): Current Conception Inc. 
Smith J, Edward W, Michael D. 2004. Effect of Chitosan on 
Epithelial Cell Tight Junctions. Pharm Res. 21:43-49. 
Ugwoke MI, Agu RU, Verbeke Nb, Kinget R. 2005. Nasal 
mucoadhesive drug delivery: Background, applications, 
trends and future perspectives. Adv Drug Deliv Rev. 
57:1640-1665. 
Ulrika W, P. Elena, J. Björn. 2005. Transfer of morphine 
along the olfactory pathway to the central nervous 
system after nasal administration to rodents. Eur J 
Pharm Sci. 24:565-573. 
Vasir JK, Tambwekar K, Garg S. 2003. Bioadhesive 
microspheres as a controlled drug delivery system. Int J 
Pharm. 255:13–32. 
Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ. 2002. 
Design of biodegradable particles for protein delivery. J 
Control Release. 78:15-24. 
Vyas TK, Aliasgar S, Sudhanva M, Ambikanandan M. 
2005. Intranasal drug delivery for brain targeting. 
Current Drug Delivery. 2:165-175. 
Wang, X.M, N. Chi, X. Tang. 2008. Preparation of estradiol 
chitosan nanoparticles from improving nasal absorption 
and brain targeting. Eur J Pharma Biopharma. 70:735-
740. 
Xu Y, Du Y. 2003. Effect of molecular structure of chitosan 
on protein delivery properties of chitosan nanoparticles. 
Int J Pharm. 250: 215-226. 
Yoshida C, Nakao T. 2005. Response of plasma cortisol and 
progesterone after ACTH challenge in ovariectomized 
lactating dairy cows. J Reprod Dev. 51:99-107. 
Zengshuan MA, Yeoh HH, Lee YL. 2002. Formulation pH 
modulates the interaction of insulin with chitosan 
nanoparticles. J Pharm Sci. 91: 1396-1404. 
Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. 2004. 
Preparation of nimodipineloaded microemulsion for 
intranasal delivery and evaluation of the targeting 
efficiency to brain. Int J Pharm. 275:85-96. 
Zhang H, Oh M, Allen C, Kumacheva E. 2004. Monodisperse 
chitosan nanoparticles for mucosal drug delivery. 
Biomacromolecules. 5:2461-2468. 
Zhang L, Kosaraju SL. 2007. Biopolymeric delivery system 
for controlled release of polyphenolic antioxidants. Eur 
Polymer J. 43:2956-2966. 
 
